To determine how the loss of CANX modifies the effects of correctors on CF variants with divergent theratypes, we employed co-immunoprecipitation coupled to mass spectrometry to compare the interactomes of a series of CF variants that exhibit distinct dependencies on CANX (Figure 6A). Here, CANX is linked to cystic fibrosis.